By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


SEARCH JOBS








Company News
Regen BioPharma Receives Positive Data From Preclinical Studies Of Its Small Molecule NR2F6 Modulators 9/20/2016 9:47:37 AM
Regen BioPharma Responds To FDA On dCellVax Gene-Silenced Breast Cancer Immunotherapy 9/15/2016 10:36:51 AM
Regen BioPharma Updates Shareholders On Status Of Non-Dilutive Funding Opportunities 8/25/2016 2:14:40 PM
Regen BioPharma Receives New Preliminary HemaXellerate Clinical Data On Bone Marrow Suppression From Pan Am Cancer Treatment Center 8/16/2016 11:27:19 AM
Regen BioPharma Files Composition Of Matter Patent Application On NR2F6 Modulating Small Molecules 7/27/2016 8:32:56 AM
Regen BioPharma President Harry Lander Provides Mid-Year Update On Company's Progress And Developments 7/13/2016 6:30:55 AM
Regen BioPharma Enters Into Open Innovation Drug Discovery Program Agreement With Eli Lilly (LLY) 6/30/2016 6:41:11 AM
Regen BioPharma 's Small Molecule Drug Screening Program Uncovers Activators Of NR2F6 6/15/2016 10:58:06 AM
Regen BioPharma Retains Objective Capital Partners, LLC To Explore Non-Dilutive Funding Opportunities 6/8/2016 9:26:04 AM
Regen BioPharma Discusses Its Major Small Molecule Drug Screening Program Targeting Immune Checkpoint NR2F6 6/2/2016 11:20:13 AM
123456789
//-->